Samsung Biologics has unveiled plans to break ground for a fourth plant this year. The move is part of its long-term strategy to maximize its operational efficiency and scale up its development and manufacturing capabilities in response to growing biomanufacturing demands. The company also said that it is in negotiations with the authorities at IFEZ (Incheon Free Economic Zone) to purchase additional land for its second bio complex.   Upon finalization of the terms under negotiation, the total s...